 | • レポートコード：GIR-203B16137 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| DPTワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のDPTワクチンの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のDPTワクチンの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 DPTワクチン市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・DTaP、Tdap、DTwP 用途別セグメントは次のように区分されます。 ・12か月下、12か月上 世界のDPTワクチン市場の主要な市場プレーヤーは以下のとおりです。 ・Sanofi Pasteur、GSK、Mitsubishi Tanabe Pharma、KM Biologics、Wuhan Institute of Biological Products、Walvax Biotechnology、Chengdu Institute of Biological Products、Minhai Biotechnology 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、DPTワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なDPTワクチンメーカーの企業概要、2019年～2021年までのDPTワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なDPTワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別DPTワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのDPTワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのDPTワクチン市場予測を収録しています。 ・第12、13、14章では、DPTワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Sanofi Pasteur、GSK、Mitsubishi Tanabe Pharma、KM Biologics、Wuhan Institute of Biological Products、Walvax Biotechnology、Chengdu Institute of Biological Products、Minhai Biotechnology ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：DTaP、Tdap、DTwP ・用途別分析2016年-2026年：12か月下、12か月上 ・DPTワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・DPTワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・DPTワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・DPTワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・DPTワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The DPT Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global DPT Vaccines size is estimated to be million in 2021 from USD 5189.5 million in 2020, with a change of % between 2020 and 2021. The global DPT Vaccines market size is expected to grow at a CAGR of 3.3% for the next five years.
Market segmentation
DPT Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DTaP
Tdap
DTwP
Market segment by Application can be divided into
12 Months Below
12 Months Above
The key market players for global DPT Vaccines market are listed below:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe DPT Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of DPT Vaccines, with price, sales, revenue and global market share of DPT Vaccines from 2019 to 2021.
Chapter 3, the DPT Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DPT Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and DPT Vaccines market forecast, by regions, type and age, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe DPT Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 DPT Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global DPT Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 DTaP
1.2.3 Tdap
1.2.4 DTwP
1.3 Market Analysis by Age
1.3.1 Overview: Global DPT Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global DPT Vaccines Market Size & Forecast
1.4.1 Global DPT Vaccines Sales in Value (2016-2026))
1.4.2 Global DPT Vaccines Sales in Volume (2016-2026)
1.4.3 Global DPT Vaccines Price by Type (2016-2026) & (US$/Dose)
1.5 Global DPT Vaccines Production Capacity Analysis
1.5.1 Global DPT Vaccines Total Production Capacity (2016-2026)
1.5.2 Global DPT Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 DPT Vaccines Market Drivers
1.6.2 DPT Vaccines Market Restraints
1.6.3 DPT Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur DPT Vaccines Product and Services
2.1.4 Sanofi Pasteur DPT Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK DPT Vaccines Product and Services
2.2.4 GSK DPT Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Mitsubishi Tanabe Pharma
2.3.1 Mitsubishi Tanabe Pharma Details
2.3.2 Mitsubishi Tanabe Pharma Major Business
2.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Product and Services
2.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 KM Biologics
2.4.1 KM Biologics Details
2.4.2 KM Biologics Major Business
2.4.3 KM Biologics DPT Vaccines Product and Services
2.4.4 KM Biologics DPT Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Wuhan Institute of Biological Products
2.5.1 Wuhan Institute of Biological Products Details
2.5.2 Wuhan Institute of Biological Products Major Business
2.5.3 Wuhan Institute of Biological Products DPT Vaccines Product and Services
2.5.4 Wuhan Institute of Biological Products DPT Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Walvax Biotechnology
2.6.1 Walvax Biotechnology Details
2.6.2 Walvax Biotechnology Major Business
2.6.3 Walvax Biotechnology DPT Vaccines Product and Services
2.6.4 Walvax Biotechnology DPT Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Chengdu Institute of Biological Products
2.7.1 Chengdu Institute of Biological Products Details
2.7.2 Chengdu Institute of Biological Products Major Business
2.7.3 Chengdu Institute of Biological Products DPT Vaccines Product and Services
2.7.4 Chengdu Institute of Biological Products DPT Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Minhai Biotechnology
2.8.1 Minhai Biotechnology Details
2.8.2 Minhai Biotechnology Major Business
2.8.3 Minhai Biotechnology DPT Vaccines Product and Services
2.8.4 Minhai Biotechnology DPT Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 DPT Vaccines Sales by Manufacturer
3.1 Global DPT Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global DPT Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in DPT Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 DPT Vaccines Manufacturer Market Share
3.4.2 Top 6 DPT Vaccines Manufacturer Market Share
3.5 Global DPT Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and DPT Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global DPT Vaccines Market Size by Region
4.1.1 Global DPT Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global DPT Vaccines Revenue by Region (2016-2026)
4.2 North America DPT Vaccines Revenue (2016-2026)
4.3 Europe DPT Vaccines Revenue (2016-2026)
4.4 Asia-Pacific DPT Vaccines Revenue (2016-2026)
4.5 South America DPT Vaccines Revenue (2016-2026)
4.6 Middle East and Africa DPT Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global DPT Vaccines Sales in Volume by Type (2016-2026)
5.2 Global DPT Vaccines Revenue by Type (2016-2026)
5.3 Global DPT Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global DPT Vaccines Sales in Volume by Application (2016-2026)
6.2 Global DPT Vaccines Revenue by Application (2016-2026)
6.3 Global DPT Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America DPT Vaccines Sales by Type (2016-2026)
7.2 North America DPT Vaccines Sales by Application (2016-2026)
7.3 North America DPT Vaccines Market Size by Country
7.3.1 North America DPT Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America DPT Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe DPT Vaccines Sales by Type (2016-2026)
8.2 Europe DPT Vaccines Sales by Application (2016-2026)
8.3 Europe DPT Vaccines Market Size by Country
8.3.1 Europe DPT Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe DPT Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific DPT Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific DPT Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific DPT Vaccines Market Size by Region
9.3.1 Asia-Pacific DPT Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific DPT Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America DPT Vaccines Sales by Type (2016-2026)
10.2 South America DPT Vaccines Sales by Application (2016-2026)
10.3 South America DPT Vaccines Market Size by Country
10.3.1 South America DPT Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America DPT Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa DPT Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa DPT Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa DPT Vaccines Market Size by Country
11.3.1 Middle East & Africa DPT Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa DPT Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 DPT Vaccines Typical Distributors
12.3 DPT Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global DPT Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global DPT Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur DPT Vaccines Product and Services
Table 6. Sanofi Pasteur DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK DPT Vaccines Product and Services
Table 10. GSK DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Mitsubishi Tanabe Pharma Major Business
Table 13. Mitsubishi Tanabe Pharma DPT Vaccines Product and Services
Table 14. Mitsubishi Tanabe Pharma DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 16. KM Biologics Major Business
Table 17. KM Biologics DPT Vaccines Product and Services
Table 18. KM Biologics DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 20. Wuhan Institute of Biological Products Major Business
Table 21. Wuhan Institute of Biological Products DPT Vaccines Product and Services
Table 22. Wuhan Institute of Biological Products DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Walvax Biotechnology Major Business
Table 25. Walvax Biotechnology DPT Vaccines Product and Services
Table 26. Walvax Biotechnology DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 28. Chengdu Institute of Biological Products Major Business
Table 29. Chengdu Institute of Biological Products DPT Vaccines Product and Services
Table 30. Chengdu Institute of Biological Products DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 32. Minhai Biotechnology Major Business
Table 33. Minhai Biotechnology DPT Vaccines Product and Services
Table 34. Minhai Biotechnology DPT Vaccines Sales (M Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global DPT Vaccines Sales by Manufacturer (2019-2021e) & (M Doses)
Table 36. Global DPT Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in DPT Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global DPT Vaccines Production Capacity by Company, (M Doses): 2020 VS 2021
Table 39. Head Office and DPT Vaccines Production Site of Key Manufacturer
Table 40. DPT Vaccines New Entrant and Capacity Expansion Plans
Table 41. DPT Vaccines Mergers & Acquisitions in the Past Five Years
Table 42. Global DPT Vaccines Sales by Region (2016-2021e) & (M Doses)
Table 43. Global DPT Vaccines Sales by Region (2021-2026) & (M Doses)
Table 44. Global DPT Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global DPT Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 46. Global DPT Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 47. Global DPT Vaccines Sales by Type (2021-2026) & (M Doses)
Table 48. Global DPT Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global DPT Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 50. Global DPT Vaccines Price by Type (2016-2021e) & (US$/Dose)
Table 51. Global DPT Vaccines Price by Type (2021-2026) & (US$/Dose)
Table 52. Global DPT Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 53. Global DPT Vaccines Sales by Application (2021-2026) & (M Doses)
Table 54. Global DPT Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global DPT Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 56. Global DPT Vaccines Price by Application (2016-2021e) & (US$/Dose)
Table 57. Global DPT Vaccines Price by Application (2021-2026) & (US$/Dose)
Table 58. North America DPT Vaccines Sales by Country (2016-2021e) & (M Doses)
Table 59. North America DPT Vaccines Sales by Country (2021-2026) & (M Doses)
Table 60. North America DPT Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America DPT Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 62. North America DPT Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 63. North America DPT Vaccines Sales by Type (2021-2026) & (M Doses)
Table 64. North America DPT Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 65. North America DPT Vaccines Sales by Application (2021-2026) & (M Doses)
Table 66. Europe DPT Vaccines Sales by Country (2016-2021e) & (M Doses)
Table 67. Europe DPT Vaccines Sales by Country (2021-2026) & (M Doses)
Table 68. Europe DPT Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe DPT Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe DPT Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 71. Europe DPT Vaccines Sales by Type (2021-2026) & (M Doses)
Table 72. Europe DPT Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 73. Europe DPT Vaccines Sales by Application (2021-2026) & (M Doses)
Table 74. Asia-Pacific DPT Vaccines Sales by Region (2016-2021e) & (M Doses)
Table 75. Asia-Pacific DPT Vaccines Sales by Region (2021-2026) & (M Doses)
Table 76. Asia-Pacific DPT Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific DPT Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific DPT Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 79. Asia-Pacific DPT Vaccines Sales by Type (2021-2026) & (M Doses)
Table 80. Asia-Pacific DPT Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 81. Asia-Pacific DPT Vaccines Sales by Application (2021-2026) & (M Doses)
Table 82. South America DPT Vaccines Sales by Country (2016-2021e) & (M Doses)
Table 83. South America DPT Vaccines Sales by Country (2021-2026) & (M Doses)
Table 84. South America DPT Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America DPT Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 86. South America DPT Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 87. South America DPT Vaccines Sales by Type (2021-2026) & (M Doses)
Table 88. South America DPT Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 89. South America DPT Vaccines Sales by Application (2021-2026) & (M Doses)
Table 90. Middle East & Africa DPT Vaccines Sales by Country (2016-2021e) & (M Doses)
Table 91. Middle East & Africa DPT Vaccines Sales by Country (2021-2026) & (M Doses)
Table 92. Middle East & Africa DPT Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa DPT Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa DPT Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 95. Middle East & Africa DPT Vaccines Sales by Type (2021-2026) & (M Doses)
Table 96. Middle East & Africa DPT Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 97. Middle East & Africa DPT Vaccines Sales by Application (2021-2026) & (M Doses)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. DPT Vaccines Typical Distributors
Table 101. DPT Vaccines Typical Customers
List of Figures
Figure 1. DPT Vaccines Picture
Figure 2. Global DPT Vaccines Sales Market Share by Type in 2020
Figure 3. DTaP
Figure 4. Tdap
Figure 5. DTwP
Figure 6. Global DPT Vaccines Sales Market Share by Application in 2020
Figure 7. 12 Months Below
Figure 8. 12 Months Above
Figure 9. Global DPT Vaccines Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026
Figure 10. Global DPT Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global DPT Vaccines Sales (2016-2026) & (M Doses)
Figure 12. Global DPT Vaccines Price by Type (2016-2026) & (US$/Dose)
Figure 13. Global DPT Vaccines Production Capacity (2016-2026) & (M Doses)
Figure 14. Global DPT Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. DPT Vaccines Market Drivers
Figure 16. DPT Vaccines Market Restraints
Figure 17. DPT Vaccines Market Trends
Figure 18. Global DPT Vaccines Sales Market Share by Manufacturer in 2020
Figure 19. Global DPT Vaccines Revenue Market Share by Manufacturer in 2020
Figure 20. DPT Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 DPT Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 DPT Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 23. Global DPT Vaccines Sales Market Share by Region (2016-2026)
Figure 24. Global DPT Vaccines Revenue Market Share by Region (2016-2026)
Figure 25. North America DPT Vaccines Revenue (2016-2026) & (USD Million)
Figure 26. Europe DPT Vaccines Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific DPT Vaccines Revenue (2016-2026) & (USD Million)
Figure 28. South America DPT Vaccines Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa DPT Vaccines Revenue (2016-2026) & (USD Million)
Figure 30. Global DPT Vaccines Sales Market Share by Type (2016-2026)
Figure 31. Global DPT Vaccines Revenue Market Share by Type (2016-2026)
Figure 32. Global DPT Vaccines Price by Type (2016-2026) & (US$/Dose)
Figure 33. Global DPT Vaccines Sales Market Share by Application (2016-2026)
Figure 34. Global DPT Vaccines Revenue Market Share by Application (2016-2026)
Figure 35. Global DPT Vaccines Price by Application (2016-2026) & (US$/Dose)
Figure 36. North America DPT Vaccines Sales Market Share by Type (2016-2026)
Figure 37. North America DPT Vaccines Sales Market Share by Application (2016-2026)
Figure 38. North America DPT Vaccines Sales Market Share by Country (2016-2026)
Figure 39. North America DPT Vaccines Revenue Market Share by Country (2016-2026)
Figure 40. United States DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe DPT Vaccines Sales Market Share by Type (2016-2026)
Figure 44. Europe DPT Vaccines Sales Market Share by Application (2016-2026)
Figure 45. Europe DPT Vaccines Sales Market Share by Country (2016-2026)
Figure 46. Europe DPT Vaccines Revenue Market Share by Country (2016-2026)
Figure 47. Germany DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific DPT Vaccines Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific DPT Vaccines Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific DPT Vaccines Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific DPT Vaccines Revenue Market Share by Region (2016-2026)
Figure 56. China DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America DPT Vaccines Sales Market Share by Type (2016-2026)
Figure 63. South America DPT Vaccines Sales Market Share by Application (2016-2026)
Figure 64. South America DPT Vaccines Sales Market Share by Country (2016-2026)
Figure 65. South America DPT Vaccines Revenue Market Share by Country (2016-2026)
Figure 66. Brazil DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa DPT Vaccines Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa DPT Vaccines Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa DPT Vaccines Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa DPT Vaccines Revenue Market Share by Country (2016-2026)
Figure 72. Turkey DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa DPT Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
ポリマープレフィルドシリンジのグローバル市場 2021年：企業別、地域別、種類・用途別 The Polymer Prefilled Syringe market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…